Health News

Femara showed reduced risk of death by 13% (P=0.08) versus tamoxifen, despite inclusion of patients who had switched over from tamoxifen to Femara during the study period, following the study’s unblinding

Read more

Filed under: General Health News
Tags: Breast Cancer, cancer, General Health News, Surgery

Related posts

• Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size (0)
  New data released demonstrates that the addition of Zometa (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces the size of breast tumors more effectively than chemotherapy alone in women with early-stage disease. Read more [tags] General Health News [/tags]
  
  
• Study examines risk factors for cancer in unaffected breast of breast cancer patients (0)
  (American Cancer Society) A new study identifies certain patient and tumor characteristics that may help indicate which breast cancer patients would be the most likely to benefit from preventive surgery to remove the unaffected breast. Read more [tags] General Health News [/tags]
  
  
• Screening May Eventually Reduce Additional Breast Surgery (0)
  A team of researchers at the University of California, San Diego (UCSD) and the Moores UCSD Cancer Center have developed a rapid, automated image screening process to distinguish breast cancer cells from normal cells. Read more [tags] General Health News [/tags]
  
  
• Delays in radiation therapy lead to increased breast cancer recurrence (0)
  (New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College) A new analysis of the National Cancer Institute's cancer registry has found that as many as one in five older women experience delayed or incomplete radiation treatment following breast-conserving surgery and that this suboptimal care can lead to worse outcomes. Read more [tags] General Health News [/tags]
  
  
• Confusing risk information may lead breast cancer patients to make poor treatment choices (0)
  (University of Michigan Health System) A new study from researchers at the University of Michigan Comprehensive Cancer Center found that a tool commonly used by doctors to estimate the risk of a woman's breast cancer returning after surgery is not very effective at explaining risk to patients. As a result, women with breast cancer may [...]